Clinical Trial: A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naive Participants With Active Psoriatic Arthritis

U.S., March 18 -- ClinicalTrials.gov registry received information related to the study (NCT06878404) titled 'A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naive Participants With Active Psoriatic Arthritis' on March 13.

Brief Summary: The purpose of this study is to evaluate the efficacy of icotrokinra compared to placebo in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.

Study Start Date: Feb. 21

Study Type: INTERVENTIONAL

Condition: Arthritis, Psoriatic

Intervention: DRUG: Icotrokinra

Icotrokinra will be administered.

DRUG: Placebo

Placebo will be administered.

DRUG: Active reference comparator

Active reference comparator drug ...